[go: up one dir, main page]

PE20010763A1 - Derivados de higromicina - Google Patents

Derivados de higromicina

Info

Publication number
PE20010763A1
PE20010763A1 PE2000001146A PE0011462000A PE20010763A1 PE 20010763 A1 PE20010763 A1 PE 20010763A1 PE 2000001146 A PE2000001146 A PE 2000001146A PE 0011462000 A PE0011462000 A PE 0011462000A PE 20010763 A1 PE20010763 A1 PE 20010763A1
Authority
PE
Peru
Prior art keywords
alkyl
cr9r10
nr3r4
link
nr3cor4
Prior art date
Application number
PE2000001146A
Other languages
English (en)
Inventor
Takushi Kaneko
Ii Robert Gerald Linde
Matthew Merrill Hayward
Katherine Elizabeth Brighty
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20010763A1 publication Critical patent/PE20010763A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A DERIVADOS DE HIGROMICINA UTILES COMO AGENTES ANTIBACTERIANOS Y ANTIPROTOZOARIOS DE FORMULA I, DONDE X ES H, F, OH, NH2; Y ES O, CH2; Z1 ES R3; Z2 ES OR13; Z1 ES H; Z2 ES R3, NR3R4, NR3COR4, F; Z1 Y Z2 FORMAN =O, =NOR3; W1 ES R3; W2 ES OR13; W1 ES H Y W2 ES R3, NR3R4, NR3COR4, F; W1 Y W2 FORMAN =O, =NOR; V ES (R1)(R2)(R12)-C, R30C0, R3R4NCO; R3OR4NCO, GRUPO a, -C-(R3)-O-N=CR14)(R13), ENTRE OTROS; R3 Y R4 FORMAN UN GRUPO HETEROCICLO DE 4-10 MIEMBROS OPCIONALMENTE SUSTITUIDO CON R5; R1 ES H, R2 ES NR3R4; R1 Y R2 FORMAN O, =N-OR3, =C(R5)X1X2R8; X1 ES CR9R10; X2 ES CR9R10, SOn, NR9, O; n ES 0-2; CUANO X2 ES NR9; R8 Y R9 SON UN HETEROCICLO DE 5-12 MIEMBROS OPCIONALMENTE SUSTITUIDO CON R6; X1 Y X2 SON UN ENLACE; CUANDO X1 ES UN ENLACE; X2 ES UN ENLACE, CR9R10; R3 ES H, ALQUILO C1-C10, ENTRE OTROS; R4 ES H, ALQUILO C1-C10; R6 ES ALQUILO C1-C10, ALQUENILO C2-C10, ENTRE OTROS; R7 ES H, ALQUILO C1-C10, CICLOALQUILO C3-C10, ENTRE OTROS; R8 ES R3, COR3, CONR9R3; TAMBIEN SE REFIERE A UNA COMPOSICION QUE COMPRENDE ADEMAS BETALACTAMA, QUINOLONA, TETRACICLINA, ESTREPTOGRAMINA, AMINOGLICOSIDO, MACROLIDO. UN COMPUESTO PREFERIDO ES BENCILOXIAMIDA DEL ACIDO (2S,3S,4S,5S)-3,4-DIHIDROXI-5-(2-HIDROXI-4-(2-((3aS,4R,5R,6S,7R,7aR)-4,6,7-TRIHIDROXIHEXAHIDROBENZO(1,3)DIOXOL-5-ILCARBAMOIL)PROPENIL)FENOXI)TETRAHIDROFURAN-2-CARBOXILICO
PE2000001146A 1999-10-29 2000-10-26 Derivados de higromicina PE20010763A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16258199P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
PE20010763A1 true PE20010763A1 (es) 2001-07-25

Family

ID=22586256

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000001146A PE20010763A1 (es) 1999-10-29 2000-10-26 Derivados de higromicina

Country Status (32)

Country Link
US (1) US6562792B1 (es)
EP (1) EP1224197A1 (es)
JP (1) JP2003512473A (es)
KR (1) KR20020063885A (es)
CN (1) CN1382150A (es)
AP (1) AP2002002494A0 (es)
AR (1) AR023282A1 (es)
AU (1) AU7549400A (es)
BG (1) BG106727A (es)
BR (1) BR0015153A (es)
CA (1) CA2389191A1 (es)
CO (1) CO5261498A1 (es)
CZ (1) CZ20021355A3 (es)
EA (1) EA200200292A1 (es)
EE (1) EE200200228A (es)
GT (1) GT200000185A (es)
HK (1) HK1049672A1 (es)
HU (1) HUP0203525A3 (es)
IL (1) IL148577A0 (es)
IS (1) IS6311A (es)
MA (1) MA26838A1 (es)
MX (1) MXPA02004360A (es)
NO (1) NO20021850D0 (es)
OA (1) OA12081A (es)
PA (1) PA8505801A1 (es)
PE (1) PE20010763A1 (es)
PL (1) PL357083A1 (es)
SK (1) SK5472002A3 (es)
SV (1) SV2002000211A (es)
TN (1) TNSN00211A1 (es)
TR (1) TR200201145T2 (es)
WO (1) WO2001030795A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152984A0 (en) * 2000-06-02 2003-06-24 Pfizer Prod Inc Hygromycin a derivatives for the treatment of bacterial and protozoal infections
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
US7923439B2 (en) 2008-10-15 2011-04-12 Tyco Healthcare Group Lp Hydroxamate compositions
WO2020041179A1 (en) * 2018-08-20 2020-02-27 Northeastern University Hygromycin a compounds and methods of treating spirochete diseases
AU2020397059A1 (en) 2019-12-06 2022-07-21 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels
CN117794920A (zh) 2021-06-04 2024-03-29 沃泰克斯药物股份有限公司 N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004303B1 (ru) * 1998-12-02 2004-02-26 Пфайзер Продактс Инк. Производные гигромицина а в качестве антибактериальных агентов

Also Published As

Publication number Publication date
CN1382150A (zh) 2002-11-27
IS6311A (is) 2002-03-19
NO20021850L (no) 2002-04-19
EP1224197A1 (en) 2002-07-24
TR200201145T2 (tr) 2002-09-23
HUP0203525A3 (en) 2003-08-28
AR023282A1 (es) 2002-09-04
OA12081A (en) 2006-05-04
PA8505801A1 (es) 2002-08-26
PL357083A1 (en) 2004-07-12
NO20021850D0 (no) 2002-04-19
GT200000185A (es) 2002-04-18
CZ20021355A3 (cs) 2002-11-13
KR20020063885A (ko) 2002-08-05
SK5472002A3 (en) 2003-02-04
BG106727A (bg) 2003-01-31
JP2003512473A (ja) 2003-04-02
SV2002000211A (es) 2002-07-16
AP2002002494A0 (en) 2002-06-30
IL148577A0 (en) 2002-09-12
US6562792B1 (en) 2003-05-13
WO2001030795A1 (en) 2001-05-03
AU7549400A (en) 2001-05-08
CO5261498A1 (es) 2003-03-31
MA26838A1 (fr) 2004-12-20
HUP0203525A2 (hu) 2003-02-28
TNSN00211A1 (fr) 2005-11-10
MXPA02004360A (es) 2002-11-07
BR0015153A (pt) 2002-07-16
CA2389191A1 (en) 2001-05-03
EE200200228A (et) 2003-06-16
EA200200292A1 (ru) 2002-10-31
HK1049672A1 (zh) 2003-05-23

Similar Documents

Publication Publication Date Title
PE20010763A1 (es) Derivados de higromicina
AR060618A1 (es) Compuesto de ciclohexilpirazol-lactama composicion farmaceutica que comprende dicho compuesto su uso para la preparacion de un medicamento e intermediarios para prepararlo
PE20040071A1 (es) Indazoles substituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion
ES2612921T3 (es) Compuestos de difluorolactama como agonistas selectivos del receptor EP4 para su uso en el tratamiento de enfermedades y afecciones mediadas por EP4
MY133385A (en) Benzazoles: benzoxazoles, benzthiazole and benzimidazole derivatives
BR0110240A (pt) Composto, processo para a preparação de um composto, processo para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto, e, composição farmacêutica
PE20030759A1 (es) Uso de ureas de benzotiazoles
PE20020468A1 (es) Compuestos macrolidos como agentes antibacterianos y antiprotozoarios
PE20050157A1 (es) Derivados de n-acil nitrogeno heterociclicos como ligandos del receptor activador del proliferador de peroxisoma (ppar)
PE20071137A1 (es) Derivados de 8-piracin-s-espiropirimidintriona oxaquinolina como agentes antibacterianos
AR062258A1 (es) Compuestos heterociclicos condensados de tieno-pirrol, composiciones farmaceuticas que los contienen y usos para el tratamiento de infecciones por hcv
PE20010299A1 (es) DERIVADOS DE DECAHIDROISOQUINOLINA COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR iGLUR5
IL66853A (en) Pharmaceutical compositions comprising levallorphan derivatives
GB1363222A (en) Substituted sulphonylacetamido cephalosporins
PE20080283A1 (es) Profarmacos antimicrobianos de oxazolidinona
BR9911145A (pt) Composto, uso de um composto, composição farmacêutica, e, processo para tratamento de um mamìfero e para a preparação de compostos
Sunagawa et al. The structural aspects of carbapenem antibiotics
PE20070010A1 (es) Penemes triciclicos de 6-alquilideno como inhibidores de beta-lactasas clase d
NZ240441A (en) Thiazol- or thiadiazol-substituted 7-acyl-3-substituted carbamoyloxy cephem derivatives and antibacterial compositions thereof; cephem intermediates
GB1423741A (en) Derivatives of cephalosporin processes for their preparation and compositions incorporating them
DE69920039D1 (de) Quinapril magnesium enthaltende, pharmazeutisch wirksame zusammensetzung
ES403126A1 (es) Procedimiento para la obtencion de una composicion antibac-teriana.
PE20070403A1 (es) COMPOSICION FARMACEUTICA QUE COMPRENDE CEFEPIME Y DERIVADOS DE 6-ALQUILIDEN-PENEM BICICLICOS COMO INHIBIDORES DE ß-LACTAMASA
DE3785868D1 (de) Tierwachstum foerdernde mittel.
NZ334087A (en) 11-acetyl-12,13-dioxabicyclo[8.2.1]-tridecenone derivatives

Legal Events

Date Code Title Description
FA Abandonment or withdrawal